日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NK92 cells stably transfected with CD16 are efficient against multiple myeloma cells ex vivo and in vivo, especially if combined with daratumumab

稳定转染CD16的NK92细胞在体外和体内均能有效对抗多发性骨髓瘤细胞,尤其是在与达雷妥尤单抗联合使用时。

Giraldos, David; Galano-Frutos, Evelyn; Cambronero-Arregui, Laura; Beltrán Visiedo, Manuel; Romanos, Eduardo; Reina-Ortiz, Chantal; Azaceta, Gemma; Martínez-Lázaro, Beatriz; Menéndez-Jándula, Bárbara; García-Romero, Alejandro; Jiménez-Albericio, Francisco Javier; Marzo, Isabel; Naval, Javier; Anel, Alberto

Alisertib and Barasertib Induce Cell Cycle Arrest and Mitochondria-Related Cell Death in Multiple Myeloma with Enhanced Efficacy Through Sequential Combination with BH3-Mimetics and Panobinostat.

Alisertib 和 Barasertib 可诱导多发性骨髓瘤细胞周期停滞和线粒体相关细胞死亡,通过与 BH3 模拟物和帕比司他序贯联合使用可增强疗效

Benedi Andrea, Beltrán-Visiedo Manuel, Jiménez-Alduán Nelia, Serrano-Del Valle Alfonso, Anel Alberto, Naval Javier, Marzo Isabel

MHC-I modulation due to changes in tumor cell metabolism regulates tumor sensitivity to CTL and NK cells

肿瘤细胞代谢变化引起的MHC-I调控影响肿瘤对CTL和NK细胞的敏感性。

Catalán, Elena; Charni, Seyma; Jaime, Paula; Aguiló, Juan Ignacio; Enríquez, José Antonio; Naval, Javier; Pardo, Julián; Villalba, Martín; Anel, Alberto

Human NK cells activated by EBV(+) lymphoblastoid cells overcome anti-apoptotic mechanisms of drug resistance in haematological cancer cells

EBV(+)淋巴母细胞激活的人类NK细胞可克服血液肿瘤细胞的抗凋亡耐药机制

Sánchez-Martínez, Diego; Azaceta, Gemma; Muntasell, Aura; Aguiló, Nacho; Núñez, David; Gálvez, Eva M; Naval, Javier; Anel, Alberto; Palomera, Luis; Vilches, Carlos; Marzo, Isabel; Villalba, Martín; Pardo, Julián